Talk:CCL17

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Wiki Education Foundation-supported course assignment[edit]

January 2021 - March 2021[edit]

This article was the subject of a Wiki Education Foundation-supported course assignment, between 4 January 2021 and 15 March 2021. Further details are available on the course page. Student editor(s): Immcarle147.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 09:37, 18 January 2022 (UTC)[reply]


I am going to add the following sources:

1. Korbecki, J. et al. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4. IJMS 21, 8412 (2020).

2. Furue, M. T helper type 2 signatures in atopic dermatitis. J Cutan Immunol Allergy 1, 93–99 (2018).

3. Ohue, Y. & Nishikawa, H. Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target? Cancer Sci 110, 2080–2089 (2019).

--Immcarle147 (talk) 17:00, 29 January 2021 (UTC)[reply]

January 2022 - March 2022[edit]

This article was the subject of a Wiki Education Foundation-supported course assignment, between 5 January 2022 and 11 March 2022. Further details are available on the course page. Student editor(s): Immcarle168 (article contribs).

Questions[edit]

Are there any major functions of CCL17 other than T cell recruitment through CCR4 receptors? That section seems important.--Immcarle168 (talk) 02:48, 18 January 2022 (UTC)[reply]

Sources[edit]

I have found a few sources I'm planning on drawing from that discuss the function of CCL17 as it relates to several different clinical outcomes (including multiple sclerosis (MS), other CNS autoimmunity issues, and atopic dermatitis (AD)).

Catherine, J., & Roufosse, F. (2021). What does elevated TARC/CCL17 expression tell us about eosinophilic disorders? Seminars in Immunopathology, 43(3), 439–458. https://doi.org/10.1007/s00281-021-00857-w

Chang, K.-H., Ro, L.-S., Lyu, R.-K., & Chen, C.-M. (2015). Biomarkers for neuromyelitis optica. Clinica Chimica Acta, 440, 64–71. https://doi.org/10.1016/j.cca.2014.11.004

Furue, M. (2018). T helper type 2 signatures in atopic dermatitis. Journal of Cutaneous Immunology and Allergy, 1(3), 93–99. https://doi.org/10.1002/cia2.12023

Furue, M., Ulzii, D., Vu, Y., Tsuji, G., Kido-Nakahara, M., & Nakahara, T. (2019). Pathogenesis of Atopic Dermatitis: Current Paradigm. Iranian Journal of Immunology, 16(2). https://doi.org/10.22034/iji.2019.80253

Kataoka, Y. (2014). Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis. The Journal of Dermatology, 41(3), 221–229. https://doi.org/10.1111/1346-8138.12440

Kothur, K., Wienholt, L., Brilot, F., & Dale, R. C. (2016). CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review. Cytokine, 77, 227–237. https://doi.org/10.1016/j.cyto.2015.10.001

Renert-Yuval, Y., Thyssen, J. P., Bissonnette, R., Bieber, T., Kabashima, K., Hijnen, D., & Guttman-Yassky, E. (2021). Biomarkers in atopic dermatitis—A review on behalf of the International Eczema Council. Journal of Allergy and Clinical Immunology, 147(4), 1174-1190.e1. https://doi.org/10.1016/j.jaci.2021.01.013

Saeki, H., & Tamaki, K. (2006). Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. Journal of Dermatological Science, 43(2), 75–84. https://doi.org/10.1016/j.jdermsci.2006.06.002

Scheu, S., Ali, S., Ruland, C., Arolt, V., & Alferink, J. (2017). The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity. International Journal of Molecular Sciences, 18(11), 2306. https://doi.org/10.3390/ijms18112306

Yoshie, Osamu; Matsushima, Kouji (2015). "CCR4 and its ligands: from bench to bedside". International Immunology, 27(1), 11-20. https://doi.org/10.1093/intimm/dxu079. PMID 25087232.

Additions[edit]

I reworked the "Allergies" section into a broader "Autoimmune" section where I discuss the ways that CCL17 affects several autoimmune disorders. Mostly I found information about atopic dermatitis (eczema) and some on multiple sclerosis, and then I listed several others that high levels of CCL17 is reported to correlate with.Immcarle168 (talk) 04:56, 10 March 2022 (UTC)[reply]